Related by context. All words. (Click for frequent words.) 73 atypical hyperplasia 73 nonmelanoma skin cancers 72 prostate carcinoma 72 nodal metastasis 72 axillary lymph nodes 71 endometrial hyperplasia 71 benign noncancerous 71 micrometastases 71 ovarian carcinoma 71 urothelial carcinoma 71 endometrial cancers 71 lobular carcinoma 71 prostate cancer CaP 71 mucinous 71 ductal carcinomas 70 breast carcinoma 70 lymph node metastases 70 thyroid nodules 70 osteosarcomas 70 neoplasias 70 ASCUS 70 tumoral 70 colorectal neoplasms 69 node metastases 69 axilla 69 cervical carcinoma 69 recurrent ovarian 69 hyperplastic 69 fibroadenoma 69 SLNB 69 precursor lesions 69 leiomyomas 69 ductal breast cancer 69 histological subtype 69 premalignant 69 metastatic lymph nodes 69 HGPIN 69 sentinel lymph node biopsy 69 advanced adenomas 69 endometrial carcinoma 69 histologic subtype 69 hamartomas 69 advanced adenoma 69 Adjuvant chemotherapy 68 renal cell carcinomas 68 cervical lymph nodes 68 pituitary adenomas 68 situ LCIS 68 extracapsular extension 68 gastric adenocarcinoma 68 breast carcinomas 68 nodal metastases 68 adenocarcinomas 68 proximal colon 68 epithelial ovarian 68 ductal 68 malignant ovarian 68 vulvar intraepithelial neoplasia 68 Papillary 68 precancerous condition 68 CIN3 68 lobular carcinomas 68 testicular tumors 68 HER2 positive cancers 68 premalignant lesions 68 nonmetastatic 68 Hurthle cell 68 GISTs 68 axillary dissection 68 fibrocystic 68 leiomyoma 68 Ductal carcinoma 68 operable breast cancer 67 urothelial cancer 67 intestinal metaplasia 67 adenomatous polyps 67 hematopoietic cancers 67 gastric carcinoma 67 bacteriuria 67 basal cell cancers 67 neoadjuvant therapy 67 orchitis 67 Heavy menstrual bleeding 67 lymphadenectomy 67 colorectal adenocarcinoma 67 radiographic findings 67 malignant polyps 67 pancreatic adenocarcinoma 67 metastatic lesion 67 chlamydial infection 67 bilateral oophorectomy 67 Helicobacter pylori infection 67 lymph node involvement 67 histologically 67 pelvic lymphadenectomy 67 invasive ductal carcinoma 67 metastatic prostate 67 peritoneal carcinomatosis 67 epithelial ovarian cancer 67 gastric cardia 67 histopathologic examination 67 pulmonary metastases 67 pCR 67 epithelial tumors 67 distant metastases 67 adenoma 67 pre cancerous lesion 67 malignant lesions 67 abnormal pap smears 67 fibroadenomas 67 HER2 expression 67 invasive lobular 67 squamous cell carcinoma SCC 67 incidentalomas 67 locoregional recurrence 67 fibrocystic changes 67 malignant prostate 67 HER2 positivity 67 MGUS 66 nephrogenic 66 PCa 66 axillary node 66 hamartoma 66 papillary 66 sonographically 66 papillary carcinoma 66 lymphovascular invasion 66 fibrocystic disease 66 pathologic diagnosis 66 serous ovarian cancer 66 histologically confirmed 66 bladder cancers 66 precancerous polyp 66 MYCN amplification 66 pre malignant lesions 66 testicular cancers 66 hypertrophic scars 66 TNF blocker therapy 66 colonic polyps 66 endometrioid 66 medically inoperable 66 microscopic hematuria 66 benign uterine 66 distal colon 66 lymph node metastasis 66 liver metastasis 66 colorectal adenoma 66 neoplasms 66 oophorectomy 66 Lymph node 66 neoplastic lesions 66 HER2 amplification 66 intravenous bisphosphonates 66 spontaneous regression 66 bladder tumors 66 TMPRSS2 ERG fusion 66 pancreatic lung 66 advanced neoplasia 66 lymphadenopathy 66 carcinomas 66 pancreatic prostate 66 T1c 66 total thyroidectomy 66 renal carcinoma 66 LHRH receptor positive 66 infantile hemangiomas 66 mammographically 66 squamous cell lung cancer 66 micrometastasis 66 basal cell carcinoma BCC 66 Legg Calvé Perthes disease 66 grade cervical intraepithelial 66 varicocele 66 resectable 66 adjuvant radiotherapy 66 sentinel nodes 66 breast endometrial 66 cisplatin resistant 65 surgically resectable 65 skeletal metastases 65 nonmelanoma 65 hormone receptor negative 65 oesophageal adenocarcinoma 65 neurofibromas 65 seminomas 65 colorectal carcinoma 65 atypia 65 sonographic appearance 65 lichen planus 65 hydronephrosis 65 urolithiasis 65 invasive carcinomas 65 lung metastasis 65 cervical dysplasia 65 renal tumors 65 axillary nodes 65 metaplasia 65 cytological 65 lipomas 65 neoplastic 65 abnormal Pap smears 65 mutated K ras 65 CIN2 65 axillary lymph node 65 thyroid carcinoma 65 HNSCC 65 anal lesions 65 endocervical 65 benign polyps 65 CIN2 + 65 prostate adenocarcinoma 65 immunocompetent 65 precancerous cervical 65 basal cell nevus syndrome 65 repigmentation 65 B7 H3 65 fibroids endometriosis 65 sarcomatoid 65 p# mutation 65 cervical lesions 65 tumor histology 65 tumor subtypes 65 MALT lymphoma 65 ductal cancer 65 peritoneal cancer 65 Colon polyps 65 paragangliomas 65 cranial irradiation 65 intraductal 65 carcinoid tumors 65 pathologic examination 65 papillary renal cell carcinoma 65 salpingo oophorectomy 65 malignant pleural mesothelioma 65 chorioamnionitis 65 metastatic lesions 65 lymph node dissection 65 malignant growths 65 calculi 65 ovarian malignancy 65 contralateral breast 65 choroidal neovascularization 65 lobular cancer 65 Candida infection 65 pre cancerous 65 fibroma 65 sentinel node 65 colorectal gastric 65 immunohistochemical 65 DCIS lesions 65 clinically detectable 65 HER2 overexpression 65 metastatic bladder 65 invasive ductal 65 atypical ductal hyperplasia 64 elevated LDH 64 hepatocellular carcinomas 64 locoregional 64 T1a 64 thyroid nodule 64 carotid stenosis 64 poorer prognosis 64 BRCA1 mutation carriers 64 fetal malformations 64 BRCA deficient 64 mammographic density 64 papillomas 64 HER2 receptor 64 GnRH agonists 64 thyroid carcinomas 64 extramedullary 64 nodular melanoma 64 perianal 64 histologically proven 64 pT2 64 endometrial 64 keloid scars 64 granulosa cell 64 retroperitoneal 64 neoplasm 64 NMIBC 64 precancerous cervical lesions 64 PCNSL 64 esophagogastric junction 64 malignant transformation 64 mesotheliomas 64 adrenalectomy 64 benign lesions 64 precancers 64 molar pregnancy 64 varicoceles 64 BRCA mutation carriers 64 grade squamous intraepithelial 64 sentinel lymph nodes 64 LNG IUS 64 HER2 positive breast 64 radioiodine therapy 64 underwent resection 64 pituitary adenoma 64 Sezary syndrome 64 colorectal polyp 64 metastatic gastric 64 bladder carcinoma 64 osteoid 64 intestinal polyps 64 germline mutations 64 hormone receptor status 64 differentiated thyroid 64 haematologic 64 squamous cell 64 GIST tumors 64 Benign tumors 64 adenomatous 64 situ DCIS 64 vesicoureteral reflux 64 hematologic toxicity 64 uterine tumors 64 lymph node removal 64 p# mutations 64 HER2 negative 64 immunohistochemical staining 64 invasive lobular carcinoma 64 para aortic 64 lymphomas leukemias 64 breast lesions 64 pelvic malignancies 64 adnexal mass 64 mycosis fungoides 64 nonmelanoma skin cancer 64 EUS FNA 64 LVNC 64 Surgical resection 64 pT3 64 dysplastic lesions 64 clinicopathological features 64 colorectal cancer CRC 64 uterus fallopian tubes 64 neoplastic cells 64 cytoreduction 64 angiographically 64 dysplastic 64 pleomorphic 64 neoplasia 64 recurrent metastatic 64 CP CPPS 64 underarm lymph nodes 64 core needle biopsies 64 clinicopathological 64 cervical intraepithelial neoplasia 64 dysplastic lesions caused 64 infiltrating ductal carcinoma 64 aerodigestive tract 64 chronic periodontitis 64 malignant lesion 64 ductal lobular 64 basal cell skin 64 pheochromocytoma 64 localized prostate 64 HbF 64 metastatic lung cancer 64 castrate resistant 64 nonproliferative 64 hypervascular 64 thymoma 64 hypermethylated 64 angiosarcoma 64 Sjögren syndrome 64 prostate carcinomas 64 carcinoid tumor 64 cholelithiasis 64 uveal melanoma 64 DCIS ductal carcinoma 64 pelvic lymph nodes 64 prostate ovarian 63 cystectomy 63 haematuria 63 microcalcifications 63 cytoreductive surgery 63 squamous cell cancers 63 distant metastasis 63 pelvic ultrasound 63 Histopathologic examination 63 squamous carcinoma 63 BRAF V#E mutation 63 thymectomy 63 metastatic ovarian cancer 63 NNRTI resistance 63 appendiceal 63 extracolonic findings 63 transabdominal 63 Immunohistochemical staining 63 CYT# potent vascular disrupting 63 urethral stricture 63 situ CIS 63 basal cell carcinomas 63 polypoid 63 cutaneous melanoma 63 supratentorial 63 primary hyperparathyroidism 63 benign growths 63 HBeAg negative 63 hyperplastic polyps 63 immunohistochemical analysis 63 TGFBR1 * 6A 63 Squamous 63 curative resection 63 neovascularization 63 thromboembolic disease 63 lobular involution 63 recurrent UTI 63 allogeneic HSCT 63 CIN3 + 63 Endometrial cancer 63 pathologic fractures 63 squamous 63 keratoses 63 precancer 63 intraoperative complications 63 histologic examination 63 colonoscopic 63 ALND 63 benign proliferative breast 63 precancerous tumors 63 axillary lymph node dissection 63 adenomyosis 63 glandular tissue 63 resected 63 K ras mutations 63 cancerous enlargement 63 contralateral breast cancer 63 orchiectomy 63 cholangiocarcinoma 63 leukaemias 63 needle aspiration 63 ADPKD 63 oncologic outcomes 63 cystic lesions 63 spontaneously regress 63 seminoma 63 Basal cell 63 HER2 positive tumors 63 H pylori 63 chemoresistant 63 urothelial 63 clinicopathologic 63 cytologic 63 malignant neoplasms 63 SUVmax 63 excisional biopsy 63 scintigraphic 63 clinically insignificant 63 radiochemotherapy 63 carcinoma 63 axillary 63 hepatectomy 63 astrocytomas 63 transfusion syndrome 63 lobular 63 endometrial thickness 63 lymphatic tissue 63 obstructive coronary artery 63 sonographic evaluation 63 myeloproliferative diseases 63 benign nodules 63 histological diagnosis 63 radical nephrectomy 63 lung carcinomas 63 bone scintigraphy 63 abnormal cytology 63 metastatic adenocarcinoma 63 extrapulmonary 63 IgA deficiency 63 preoperative chemotherapy 63 antiangiogenic therapy 63 pleurodesis 63 benign breast 63 N. gonorrhoeae 63 chlamydial 63 precancerous lesion 63 Endometrial 63 ALCL 63 completely resected 63 transrectal ultrasound guided 63 Postoperative complications 63 nodular 63 oligodendrogliomas 63 metachronous 63 FGFR2 gene 63 recurrent glioblastoma multiforme 63 prophylactic mastectomies 63 congenital anomalies 63 tumorigenicity 63 inherited predisposition 63 mutated BRAF gene 63 superficial bladder cancer 63 breast cancer subtypes 63 metastatic malignant melanoma 63 chromosomal rearrangement 63 minimally symptomatic 63 osteoid osteoma 63 sonographically guided 63 cervical lymph node 63 radiosensitive 63 ductal lavage 63 hilar 63 transurethral resection 63 paraganglioma 63 cervical neoplasia 63 biliary tract cancer 63 Leydig cell 63 colorectal adenomas 63 thermogram 62 nephrectomy 62 estrogen receptor negative 62 breast uterine 62 ano genital warts 62 antiandrogens 62 Immunohistochemical analysis 62 kidney cysts 62 chronic prostatitis 62 melanoma lesions 62 HPV subtypes 62 nonischemic 62 hormone refractory 62 #.#ng/ml 62 androgen dependent 62 progesterone receptor negative 62 lymphocytosis 62 eccrine 62 mediastinal lymph nodes 62 varices 62 BRCA1 mutations 62 pituitary tumors 62 rebleeding 62 anaplastic 62 GBM tumors 62 lobular breast cancer 62 untreated celiac disease 62 BRAF mutation 62 lymphocytic 62 colorectal liver metastases 62 neoadjuvant chemotherapy 62 gross hematuria 62 Chlamydia trachomatis infection 62 mesenteric 62 metastatic malignant 62 CaP 62 malignant neoplasm 62 Surgical excision 62 colorectum 62 nonsmall cell lung cancer 62 vulvar cancer 62 androgen ablation 62 squamous cell cancer 62 Radical prostatectomy 62 curable cancers 62 de novo AML 62 bone metastasis 62 neoadjuvant 62 polyposis 62 solar keratosis 62 impair fertility 62 monoclonal gammopathy 62 PAOD 62 neovascular 62 intact parathyroid hormone 62 nephrolithiasis 62 chemoradiotherapy 62 abdominal ultrasounds 62 bronchogenic carcinoma 62 tumor recurrence 62 metastatic tumors 62 Mitomycin C 62 wedge resection 62 GPC5 62 extracapsular 62 prostate cancer PCa 62 epididymitis 62 radical prostatectomy RP 62 adrenocortical 62 overexpress HER2 62 perineural invasion 62 intraepithelial neoplasia 62 neurosensory 62 cervix uteri 62 PNET 62 airway responsiveness 62 multimodality therapy 62 thoracoscopic lobectomy 62 mammary tumors 62 urine cytology 62 carotid plaques 62 chemopreventive agent 62 ectopic 62 pericardial effusion 62 cutaneous squamous cell carcinoma 62 melanocytic nevi 62 MRSA colonization 62 gadolinium enhanced 62 unresectable tumors 62 postoperative morbidity 62 recurrent VTE 62 EBRT 62 carcinoids 62 endobronchial 62 prostate cancer metastases 62 subclinical 62 oncological outcomes 62 noncancerous tumors 62 polyp recurrence 62 osteolytic 62 microsatellite instability 62 fetal chromosomal 62 malignancy 62 thyroglobulin 62 plasma kallikrein 62 gene rearrangements 62 Barrett mucosa 62 BRCA2 mutation carriers 62 Histological examination 62 adrenocortical cancer 62 sonographic findings 62 perioperative complications 62 androgen deprivation 62 colon rectal 62 pulmonary toxicity 62 urothelium 62 biochemical relapse 62 specific antigen PSA 62 trophoblast cells 62 β blockers 62 metastatic neuroendocrine tumors 62 diaper dermatitis 62 hormonally sensitive 62 postoperative chemotherapy 62 C. pneumoniae 62 ABCB1 62 KRAS mutation 62 myomas 62 thyrotoxicosis 62 relapsed ovarian cancer 62 antiphospholipid antibodies 62 elevated CRP 62 ovarian endometrial 62 supraclavicular 62 clinico pathological 62 acute leukemias 62 cerebral microbleeds 62 esophageal cancers 62 granulomatous 62 thyroid dysfunction 62 Fas ligand 62 anti angiogenic therapy 62 Bacterial vaginosis 62 amenorrhoea 62 pre cancerous growths 62 androgen receptor AR 62 histologic findings 62 gastric cancers 62 postoperative radiotherapy 62 renal pelvis 62 lumbar disk herniation 62 neuroblastomas 62 EXJADE 62 HER2 amplified 62 osteopenic 62 fatty infiltration 62 egg follicles 62 adenomatous polyp 62 basal cell cancer 62 acute aortic dissection 62 anti androgen 62 oncogenic HPV 62 BRCA2 carriers 62 histopathologic 62 taxane therapy 62 cytologically confirmed 62 benign moles 62 Hashimoto thyroiditis 62 Chronic pancreatitis 62 submandibular 62 liver metastases 62 Squamous cell carcinomas 62 anal cancers 62 haematopoietic 62 nonalcoholic steatohepatitis NASH 62 CMV infection 62 HIV HCV coinfected 62 pancreatic carcinoma 62 sonographic diagnosis 62 urothelial bladder cancer 62 endocrine therapies 62 ductal adenocarcinoma 62 adjuvant systemic 62 Sentinel node biopsy 62 cancerous polyps 62 papilloma 62 SPINK1 62 Hemangiomas 62 prostate TURP 62 node dissection 62 carcinoid 62 enucleation 62 TOP2A gene 62 Polycythemia vera 62 mammographic 62 postoperative infections 62 Benign breast 61 pyelonephritis 61 relapsed MM 61 mediastinal 61 papillary thyroid carcinoma 61 KRAS mutations 61 Venous thromboembolism 61 adjuvant radiation 61 endometrial biopsy 61 KRAS oncogene 61 Subgroup analyzes 61 fibrosarcoma 61 aromatase inhibitor therapy 61 squamous cell histology 61 Genetic variants 61 percutaneous biopsy 61 pheochromocytomas 61 metastatic colorectal 61 biochemical recurrence 61 nasopharyngeal carcinoma 61 adrenal masses 61 lung nodules 61 ovarian cervical 61 chemosensitivity 61 pulmonary metastasis 61 precocious puberty 61 colon resection 61 HG PIN 61 pre cancerous lesions 61 polyps growths 61 transitional cell carcinoma 61 histopathological 61 metastatic RCC 61 malignant ascites 61 surgically resected 61 abnormal Pap smear 61 Malignant tumors 61 Hepatocellular Carcinoma HCC 61 serum IgE 61 chemoradiation therapy 61 microdeletions 61 anterior uveitis 61 submandibular gland 61 bacterial vaginosis BV 61 ocular toxicity 61 hematuria 61 Adenomas 61 submucosal 61 IV bisphosphonates 61 esophageal gastric 61 colorectal tumors 61 Uterine fibroids 61 juvenile idiopathic arthritis 61 pulmonary dysfunction 61 cryptogenic 61 Ovary removal 61 noncancer 61 oropharyngeal 61 ultrasonographic 61 FDG uptake 61 oncogenic HPV types 61 dentinal hypersensitivity 61 catheter angiography 61 osteochondroma 61 luteal 61 genital tract infections 61 curative therapy 61 nonmalignant 61 sentinel node biopsy 61 infiltrative 61 BRCA gene mutation 61 TP# mutations 61 Wilms tumors 61 erythema nodosum 61 estrogen receptor ER 61 hereditary predisposition 61 retrograde ejaculation 61 GnRH agonist 61 P. acnes 61 carcinomatosis 61 explants 61 EGFR protein 61 metastatic renal 61 endometriosis ovarian cysts 61 esophageal squamous cell carcinoma 61 painless lump 61 CMV infections 61 uterine cancers 61 BRCA mutations 61 HER2 neu 61 mitomycin C 61 gene BRCA2 61 Thyroid nodules 61 ductal carcinoma 61 meningiomas 61 aneuploid 61 neurofibroma 61 chorionic villi 61 neuroblastoma tumors 61 trophoblasts 61 oral squamous cell 61 normal karyotype 61 myoma 61 malignant lymphoma 61 hyperbilirubinemia 61 percutaneous drainage 61 HPV# 61 chemoembolization 61 choroidal 61 cervical vaginal 61 SSc 61 Prognostic factors 61 diverticular bleeding 61 histological examination 61 pulmonary hypertension PH 61 seborrheic keratoses 61 undergoing hysterectomy 61 vesicoureteral reflux VUR 61 spinal metastases 61 bleomycin 61 lactate dehydrogenase 61 testicular germ cell 61 enteroviral infection 61 varicella infection 61 endoscopic ultrasonography 61 ALK mutations 61 Squamous cell 61 abnormal Pap 61 VATS lobectomy 61 invasive cervical cancer 61 bowel cancers 61 Acute myeloid leukemia 61 Metastatic breast cancer 61 antiestrogen 61 arterial calcification 61 genomic alterations 61 neuritic 61 azoospermia 61 genital lesions 61 kidney urologic 61 plexiform 61 malignant nodules 61 mediastinitis 61 Metastatic prostate cancer 61 endometrial cells 61 Fibroid tumors 61 TIMP 61 serologically 61 amyloid deposition 61 arthrography 61 follicular thyroid cancer 61 penile anal 61 neurologic deficits 61 gonococcal infections 61 malignant cancerous 61 lung metastases 61 solar keratoses 61 K ras mutation 61 squamous intraepithelial lesions 61 Rectal cancer 61 telangiectasia 61 tryptase 61 paternally inherited 61 polycystic ovary syndrome PCOS 61 bacterial colonization 61 thrombocytopenic 61 atrophic 61 subclinical hyperthyroidism 61 leukoplakia 61 Recurrences 61 prostate bladder 61 tunica vaginalis 61 melanocytic 61 abnormal mammogram 61 subclinical disease 61 beta estradiol 61 localized renal 61 subclinical hypothyroidism 61 NP CRNs 61 tamoxifen Nolvadex ® 61 etiologic 61 distal colon cancer 61 gastrointestinal cancers 61 ipsilateral breast 61 abnormal mammograms 61 Histologically 61 periodontal bacteria 61 androgen independent 61 prophylactic cranial irradiation 61 parathyroid 61 ovarian breast 61 neoadjuvant treatment 61 prognostic indicator 61 hip resurfacing arthroplasty 61 underwent surgical resection 61 NSCLC tumors 61 fibrous dysplasia 61 chromosomal mutations 61 Plantar warts 61 external genital lesions 61 vaginal lesions 61 splenic 61 noncardiac 61 meningeal 61 PHPT 61 secondary amenorrhea 61 hepatoma 61 Trichomonas vaginalis 61 sarcoid 61 benign prostatic hypertrophy BPH 61 surgical excision 61 oesophageal 61 MAGE A3 ASCI 61 aetiological 61 candidemia 61 cutaneous lesions 61 FGFR2 61 Metastases 61 intravesical therapy 61 pyloric stenosis 61 malignant pancreatic 61 lung adenocarcinomas 61 chest radiograph 61 SNP rs# [002] 61 ovariectomy 61 surgical biopsy 61 familial clustering 61 urethritis 61 prophylactic mastectomy 61 ocular melanoma 61 HER2 gene 61 orthotopic 61 KRAS mutations occur 61 sleeve lobectomy 61 chromosomal aberrations 61 benign prostatic hypertrophy 61 polycystic ovarian syndrome PCOS 61 histologic 61 hypogonadal 61 fallopian tube carcinoma 61 FDG PET imaging 60 H. pylori infections 60 syngeneic 60 Adenocarcinoma 60 ALT flares 60 extranodal 60 orchidectomy 60 tumor subtype 60 histopathologic findings 60 VEGF expression 60 node metastasis 60 gastroesophageal junction 60 colon tumors 60 proctitis 60 morphologic 60 multicentric 60 biliary tract 60 CD# expression [001] 60 T1DM 60 invasive fungal infection 60 epithelioid 60 ovulatory cycles 60 transvaginal sonography 60 biochemical abnormalities 60 castration resistant 60 hypercoagulable 60 anogenital 60 cervical precancers 60 cortical dysplasia 60 morphological abnormalities 60 myometrium 60 gastrointestinal stromal tumors GISTs 60 adjuvant therapy 60 prostate cancers 60 hypertrophic scarring 60 Multivariate analysis 60 penile cancers 60 lung nodule 60 skin sparing mastectomy 60 stage IIIB 60 parenchymal 60 bronchopulmonary dysplasia 60 thromboembolic 60 VUR 60 Carcinoid tumors 60 postoperative infection 60 perineural 60 presymptomatic 60 extracranial 60 adnexal masses 60 mTOR inhibitors 60 metastatic GIST